Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>Macquarie Upgrades ALI HEALTH's Rating to Outperform, Raises TP to HKD6.78
Recommend 40 Positive 65 Negative 22 |
||||
|
||||
|
Macquarie has released a report upgrading ALI HEALTH (00241.HK)'s rating from Underperform to Outperform and raising its target price from HKD3.4 to HKD6.78. The broker has also lifted its FY26-27 adjusted net profit forecasts for the company by 6% and 20%, respectively, to reflect its enhanced profitability through market consolidation. Macquarie believes the online healthcare industry has structurally improved, with market share accelerating from offline channels. Meanwhile, the integration of the 88VIP program by ALI HEALTH's parent company Alibaba should provide ALI HEALTH with additional traffic synergy benefits. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
